Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phase I Trial: D+Q in Early Alzheimers Disease, SToMP-AD The primary objective of the vanguard SToMP-AD trial was to evaluate CNS penetrance of D and Q and collect data relevant to safety of intermittent orally delivered senolytic therapy
BPC-157 | TB-500 (Capsules) Tissue Repair Blend (Oral) Blend Components: BPC-157 CAS: 137525-51-0 Formula: C 62 H 98 N 16 O 22 M.W.: 1419.5347 g/mol TB-500 CAS: 77591-33-4 Formula: C 212 H 350 N 56 O 78 S M.W.: 4963.4421 g/mol Purity: 99%+ HPLC Verified Ref No.: BTS-0500TA For Research Use Only (RUO) Not for human or veterinary use
Protocol compliance affects outcomes substantially
10.7554/eLife.15092 eLife 26 SuzukiM.SuzukiM.KitamuraY.MoriS.SatoK.DohiS.et al (2002)
US$ 23.30
US$ 20.58
US$ 21.51
US$ 26.49
US$ 22.93
US$ 20.25
US$ 27.82
